JWJui Wang

Jui Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jui Wang has a total of 154 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quality of life in hyperkalemia: baseline analysis of a cohort study of management of hyperkalemia in patients with chronic kidney disease or heart failure in Japan

    by Ken-Ei Sada, Hajime Yamazaki, Takafumi Wakita, Yosuke Yamamoto, Jui Wang, Yoshihiro Onishi, Tadateru Hamada, Ryotaro Ide, Masayoshi Takeda, Shunichi Fukuhara, et al.

    Background: Hyperkalemia is common in chronic kidney disease (CKD) and chronic heart failure (CHF), often leading to treatment dilemmas regarding renin–angiotensin–aldosterone system (RAAS) inhibitors. Although potassium binders and dietary restrictions are central to chronic management, their quality-of-life (QOL) impact remains insufficiently described. This study aimed to characterize real-world treatment patterns and evaluate treatment impact on QOL. Methods: We analyzed baseline data from a prospective cohort in Japanese nephrology and cardiology outpatient clinics. Participants were adults with CKD (≥ stage G3) or CHF (New York Heart Association class II-IV) who initiated potassium binders within 6 months. Clinical data, serum potassium values, and patient-reported outcomes (generic QOL, disease/treatment-specific QOL, and adherence measures) were obtained at enrollment. Results: Among 347 patients, the median age was 75 years, and 74% were male; 93% had CKD. At enrollment, 59% were prescribed a RAAS inhibitor. Dietary therapy was implemented in 29%. Physical scores of generic QOL were lower than population norms, whereas mental scores were comparable. Treatment-specific QOL scores suggested that potassium binders may have had a relatively small impact on QOL compared with dietary therapy. Adherence to potassium binders was high. Conclusions: Concurrent use of RAAS inhibitors and potassium binders was common, consistent with a role for binders in supporting RAAS inhibitor continuation. Potassium binders showed little perceived impact, indicating that pharmacologic potassium control may be acceptable to patients managing multiple lifestyle limitations. Study registration.: The study was registered with ClinicalTrials.gov (NCT05297409).

  • All‐Cause and Cardiovascular Mortality in Relation to Sleep Duration: A Community‐Based Cohort With Over 30 Years of Follow‐Up

    by Yu‐Chien Lin, Kuo‐Liong Chien, Hung‐Ju Lin, Ta‐Chen Su, Jui Wang

    The study investigated the association between sleep duration and the risks of all‐cause and cardiovascular death, and elucidated the mediating role of atherosclerotic markers in these associations to identify potential biological pathways. We used data from the Chin‐Shan Community Cardiovascular Cohort in Taiwan, a prospective study. After excluding individuals with incomplete data and those with cardiovascular diseases, 3305 participants were included. Participants were classified into three sleep duration groups as short (≤ 6 h), normal (7–8 h) and long (≥ 9 h) through structured questionnaires. Cox proportional hazard models and restricted cubic splines assessed the associations and non‐linear trends. Causal mediation analysis was performed to identify potential mediators. During a median of 30.8 years of follow‐up, after adjusting for potential confounding factors, long sleep duration was significantly associated with increased risks of all‐cause mortality (adjusted hazard ratio: 1.17, 95% confidence interval: 1.01, 1.35), while short sleep duration showed no significant difference. Long sleep duration was not significantly associated with cardiovascular mortality (adjusted hazard ratio: 1.18, 95% confidence interval: 0.89, 1.56). Short sleep duration showed no significant association with either outcome. No significant interactions were found in sub‐group analyses by age, sex, body mass index, hypertension and diabetes. This study found that longer sleep duration increases the risk of all‐cause mortality, which may be partially mediated by systolic blood pressure.

  • Open Access

    Nomogram for Predicting 1‐, 3‐, and 5‐Year Survival in Hemodynamically Significant Aortic Regurgitation: The ARISE Score

    by Kang Liu, Meng‐Han Tsai, Wei‐Jyun Wang, Jui Wang, Seanson Chance Ju, Masashi Amano, Chisato Izumi, Yi‐Lwun Ho, Masaaki Takeuchi, Li‐Tan Yang

    Background: A user‐friendly tool that integrates key clinical variables to estimate prognosis in aortic regurgitation is lacking. We aimed to develop and validate a nomogram‐based score to predict survival and identify high‐risk patients for timely aortic valve surgery referral. Methods and Results: From 2008 to 2022, 1229 patients (derivation data set: 764 Taiwanese; validation data set: 465 Japanese; age: 64±17 years) with isolated chronic moderately severe to severe aortic regurgitation from 3 centers were included. All echocardiograms were reviewed de novo. At a median follow‐up of 5.0 (interquartile range, 2.2–8.2) years, 204 all‐cause deaths occurred and 247 underwent aortic valve surgery within 3 months. In multivariable analysis, age ( P P P P P =0.03), and aortic valve surgery in 3 months ( P =0.03) were associated with all‐cause death. These variables, along with sex and maximal aorta diameter index, were incorporated into the combined left ventricular ejection fraction and left ventricular end‐systolic dimension index nomogram to estimate 1‐, 3‐, and 5‐year survival and to calculate the Aortic Regurgitation/Insufficiency Survival Estimation (ARISE) score. Calibration plots demonstrated good performance, with the area under the receiver operating characteristic curve reaching 0.79 in the validation data set. The left ventricular end‐systolic dimension index‐based nomogram showed similar performance. By using the tertiles of the ARISE score to risk stratify individuals, Kaplan‐Meier curves demonstrated significant survival differences among 3 risk groups in both the derivation and validation cohorts ( P <0.001). Conclusions: The ARISE score ( https://arise‐score.vercel.app/ ), which includes guideline‐recommended parameters, effectively predicts survival in patients with aortic regurgitation. It may facilitate shared decision‐making between the heart team and patients.

  • Open Access

    Characterization of clinical features and comorbidities between bipolar affective disorder with and without depressive episodes

    by Chiao-Erh Chang, Jui Wang, Yi-Ting Lin, Chih-Chiang Chiu, Ming-Hsien Hsieh, Ming-Chyi Huang, Mong-Liang Lu, Hsi-Chung Chen, Wei J. Chen, Po-Hsiu Kuo

    Backgrounds: A proportion of patients with bipolar disorder (BD) manifests with only unipolar mania (UM). This study examined relevant clinical features and psychosocial characteristics in UM compared with depressive-manic (D-M) subgroups. Moreover, comorbidity patterns of physical conditions and psychiatric disorders were evaluated between the UM and D-M groups.Methods: This clinical retrospective study (N = 1015) analyzed cases with an average of 10 years of illness duration and a nationwide population-based cohort (N = 8343) followed up for 10 years in the Taiwanese population. UM was defined as patients who did not experience depressive episodes and were not prescribed adequate antidepressant treatment during the disease course of BD. Logistic regression models adjusted for relevant covariates were used to evaluate the characteristics and lifetime comorbidities in the two groups.Results: The proportion of UM ranged from 12.91% to 14.87% in the two datasets. Compared with the D-M group, the UM group had more psychotic symptoms, fewer suicidal behaviors, a higher proportion of morningness chronotype, better sleep quality, higher extraversion, lower neuroticism, and less harm avoidance personality traits. Substantially different lifetime comorbidity patterns were observed between the two groups.Conclusions: Patients with UM exhibited distinct clinical and psychosocial features compared with patients with the D-M subtype. In particular, a higher risk of comorbid cardiovascular diseases and anxiety disorders is apparent in patients with D-M. Further studies are warranted to investigate the underlying mechanisms for diverse presentations in subgroups of BDs.


  • Inverse Association Between Fatty Liver at Baseline Ultrasonography and Remission of Type 2 Diabetes Over a 2-Year Follow-up Period

    by Hajime Yamazaki, Jui Wang, Shinichi Tauchi, Mitsuru Dohke, Nagisa Hanawa, Akio Katanuma, Yoshifumi Saisho, Tsukasa Kamitani, Shunichi Fukuhara, Yosuke Yamamoto


  • Increases in repolarization heterogeneity predict left ventricular systolic dysfunction and response to cardiac resynchronization therapy in patients with left bundle branch block

    by Hui‐Chun Huang, Kuo‐Liong Chien, Yi‐Chung Chang, Lian‐Yu Lin, Jui Wang, Yen‐Bin Liu

    Introduction: This study aimed to investigate the association between T‐wave morphology and impaired left ventricular ejection fraction (LVEF) in patients with complete left bundle branch block (cLBBB), and the predictive value of T‐wave morphology for response to cardiac resynchronization therapy (CRT).Methods and Results: We enrolled 189 patients with cLBBB on electrocardiogram performed between January 2007 and December 2011 who underwent standard echocardiography. Repolarization parameters, including the QRS‐to‐T angle (TCRT), T‐wave morphology dispersion (TMD), T‐wave loop area (PL), and T‐wave residuum (TWR), were reconstructed from digital standard 12‐lead electrocardiograms by T‐wave morphology analysis. CRT response was defined as ≥15% reduction in left ventricular end‐systolic volume at 12 months after CRT implantation. The clinical outcome endpoint was a composite of heart failure hospitalization, heart transplantation, or death during follow up (mean, 5.8 years). On logistic regression, a higher heart rate, longer QRS duration, increased TMD, and larger TWR were all independently associated with LVEF < 40%. Among 40 patients who underwent CRT, those with a larger TMD (P = .007), larger PL (P = .025), and more negative TCRT (P = .015) had better response to CRT. A large TMD (P = .018) and large PL (P = .003) were also independent predictors of the clinical outcome endpoint.Conclusions: Increases in repolarization heterogeneity in patients with cLBBB are associated with impaired LVEF. A large TMD and large PL may be useful as additional predictors of response to CRT, improving patient selection for CRT.


  • Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study

    by Hajime Yamazaki, Shinichi Tauchi, Jui Wang, Mitsuru Dohke, Nagisa Hanawa, Yoshihisa Kodama, Akio Katanuma, Yoshifumi Saisho, Tsukasa Kamitani, Shunichi Fukuhara, et al.

    Background Only a few studies have longitudinally evaluated whether fatty pancreas increases the risk of type-2 diabetes (T2D), and their results were inconsistent. Fatty pancreas is closely linked to overweight and obesity, but previous studies did not exclude overweight or obese individuals. Therefore, in this cohort study, we investigated the association between fatty pancreas and T2D incidence in lean individuals. Methods Between 2008 and 2013, 1478 nondiabetic lean individuals (i.e. body-mass index < 25 kg/m2) underwent health examinations including computed tomography (CT) and were followed for a median of 6.19 years. Fatty pancreas was evaluated by a histologically-validated method using pancreas attenuation (Hounsfield units [HU]) on CT at baseline; lower pancreas attenuation indicates more pancreatic fat. To detect incident T2D, we used fasting plasma glucose, HbA1c, and self-reports of prescribed anti-diabetes medications. Odds ratios (OR) for the association between pancreas attenuation and incident T2D were estimated using logistic regression models adjusted for likely confounders. Results T2D occurred in 61 participants (4.13%) during the follow-up period. Lower pancreas attenuation (i.e. more pancreatic fat) at baseline was associated with incident T2D (unadjusted OR per 10 HU lower attenuation: 1.56 [95% CI 1.28–1.91], p < 0.001). The multivariable-adjusted analysis revealed a similar association (adjusted OR per 10 HU lower attenuation: 1.32 [95% CI 1.06–1.63], p = 0.012). Conclusions T2D was likely to develop in lean individuals with the fatty pancreas. Among people who are neither obese nor overweight, the fatty pancreas can be used to define a group at high risk for T2D.


  • Risk for Suicidal Behavior Among Psoriasis Patients: A Nationwide Cohort Study

    by Shu-Hui Wang, Jui Wang, Ching-Chi Chi, Yu-Sheng Lin, Shih-Cheng Liao, Pei-En Chen, Tao-Hsin Tung

    The link between psoriasis and suicidality remains elusive and understudied.